NWI Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51M Buy
55,500
+54,000
+3,600% +$54.7M 2.9% 11
2025
Q4
$1.61M Sell
1,500
-27,000
-95% -$25.8M 0.07% 53
2025
Q3
$21.7M Hold
28,500
1.16% 26
2025
Q2
$22.2M Buy
28,500
+27,000
+1,800% +$21M 1.15% 24
2025
Q1
$1.24M Hold
1,500
0.16% 38
2024
Q4
$1.16M Buy
+1,500
New +$1.24M 0.05% 49
2024
Q1
Sell
-90,000
Closed -$52.5M 52
2023
Q4
$52.5M Buy
90,000
+60,000
+200% +$35M 1.3% 8
2023
Q3
$16.1M Hold
30,000
0.78% 14
2023
Q2
$14.1M Hold
30,000
2.53% 11
2023
Q1
$10.3M Buy
+30,000
New +$10.1M 1.13% 21

Other funds holding LLY

NWI Management's LLY Position: Q1 2026 in Review

NWI Management increased its Eli Lilly (LLY) stake by 3,600% in Q1 2026, buying an estimated $54.7M and bringing the position to 55,500 shares worth $51M. The position accounts for 2.9% of the portfolio, ranked #11.

NWI Management first reported a position in LLY in Q1 2023 and has held it in 10 quarters since. The position peaked at $52.5M in Q4 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NWI Management held 55,500 shares of Eli Lilly worth $51M as of Q1 2026.
  • NWI Management bought 54,000 Eli Lilly shares in Q1 2026, an estimated $54.7M.
  • Eli Lilly made up 2.9% of NWI Management's portfolio in Q1 2026, its #11 holding.
  • NWI Management first reported a position in Eli Lilly in Q1 2023 and has held it in 10 quarters since.
  • NWI Management's Eli Lilly position peaked at $52.5M in Q4 2023.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NWI Management's 13F filing for Q1 2026, filed 15 May 2026.